With 2.49 million shares changed hands, the volume of the stock remained lighter than its average volume of 2.67 million shares. The 52-week range on BBIO shows that it touched its highest point at $39.47 and its lowest point at $21.62 during that stretch. It currently has a 1-year price target of $53.43. Beta for the stock currently stands at 1.07.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of BBIO was up-trending over the past week, with a rise of 16.76%, but this was up by 2.82% over a month. Three-month performance surged to 64.88% while six-month performance rose 43.61%. The stock gained 2.50% in the past year, while it has gained 34.29% so far this year. A look at the trailing 12-month EPS for BBIO yields -2.85 with Next year EPS estimates of -2.56. For the next quarter, that number is -0.95. This implies an EPS growth rate of -26.37% for this year and 29.77% for next year. EPS is expected to grow by 58.11% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of -3.04%.
Float and Shares Shorts:
At present, 190.04 million BBIO shares are outstanding with a float of 148.37 million shares on hand for trading.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for BBIO since 9 analysts follow the stock currently. There are 9 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$2.30756 being high and -$2.69052 being low. For BBIO, this leads to a yearly average estimate of -$2.51377. Based on analyst estimates, the high estimate for the next quarter is -$0.75 and the low estimate is -$0.92. The average estimate for the next quarter is thus -$0.83.
